AXS26_DigitalGuide_Final pages - Flipbook - Page 22
WEDNESDAY, APRIL 29
10:00 AM - 10:40 AM
Margaux 1
Expanded Scope: Pharmacist Scope of Practice Opportunities
and Obstacles
Luis Lanz, Quarles & Brady; Nicholas H. Meza, Quarles & Brady
10:00 AM - 10:40 AM
Mouton 1
The Future of Cancer Care: Navigating Headwinds and Opportunities to
Advance Access, Affordability and Outcomes
Austin Fisher, Autolus Therapeutics; Micaila Ruiz, Optum; Tina Valbh,
PharmaKonnect; Christopher Van Denburg, Syneos Health
10:00 AM - 10:40 AM
Lafite 2
The Future of Digital Navigation for Specialty Pharmacy
Michael Einodshofer, Free Market Health; Daniel Knecht, Emblem Health; George
Van Antwerp, Prime Therapeutics
10:00 AM - 10:40 AM
Margaux 2
Transforming Hope into Access: Launch Excellence in Rare Diseases
Matt Barletta, Jazz Pharmaceuticals; Katie DiLorenzo, PANTHERx Rare; Melissa
Mewes, Apellis Pharmaceuticals; Austin Russian, PANTHERx Rare; Stacy Ward,
Prader-Willi Syndrome Association
10:15 AM - 11:15 AM
Lafite 1
Product Theater: Building a Smarter Specialty Strategy: How Dynamic
Solutions are Reshaping the Industry | Hosted by: Bayvrio
Gordon Romanas, Bayvrio; Alex Walters, Bayvrio
11:00 AM - 11:40 AM
Lafite 2
Addressing Physician Pain Points Through Innovation
Eric Borstein, Team PHenomenal Hope; Joel Helle, CVS Health; Glen Howell, CVS
Health; Amber McCracken, PAN Foundation
11:00 AM - 11:40 PM
Mouton 1
Beyond the Curtain: Elevating Your Patient Support Ecosystem
Denise Butler, Nuvation Bio; Casey Cormier, Stratis Group; Ryan Cox, Nexus Health
Group; Debra Jennings, Kyowa Kirin; Billy Weaver, Nexus Health Group
11:00 PM - 11:40 PM
Margaux 2
Biosimilars and Benefit Design: What Plan Sponsors Want from PBMs in
Autoimmune Management
Tu Doan, Employers Health; Laura Henry, CVS Caremark; Ernesto Munoz, Employers
Health
11:00 PM - 11:40 PM
Margaux 1
Medically Integrated Oncology Care: Evolving Approaches to
Patient-Centered Delivery
Meg Butler, Clearview Cancer Institute; Jonas Congelli, NCODA; Wafa Samara, City
of Hope; Chris Wixson, Aveo Oncology, an LG Chem company
* as of April 6, 2026
22 I DIGITAL GUIDE
